市場調査レポート

商品コード

1533599

バイオインフォマティクスの市場規模、シェア、成長分析：製品・サービス別、用途別、ソース別、セクター別、地域別 - 産業予測、2024年～2031年

Bioinformatics Market Size, Share, Growth Analysis, By Products and Services, By Application, By Source, By Sector, By Region - Industry Forecast 2024-2031

出版日: 2024年08月07日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バイオインフォマティクス市場は2022年に132億米ドルとなり、2023年の153億5,000万米ドルから、2031年までには456億米ドルに成長し、予測期間（2024年～2031年）のCAGRは16.3％で成長する見通しです。

市場の成長は、政府の支援策と相まって、研究開発需要の増加によって大きく促進されています。RasMol、AUTODOCK、BALLなどのツールを含むバイオインフォマティクスソフトウェアの進歩も、この拡大に寄与しています。これらの洗練されたツールは、バイオマーカー探索プログラムにおける正確で効果的な解析を可能にし、医薬品開発プロセスの早期毒性検出に不可欠です。バイオインフォマティクスは、生物学的データを管理・分析するためのコンピュータ技術の利用を伴うもので、この分野で重要な役割を果たしています。生物学的データの保存、評価、普及を包含し、遺伝子やタンパク質の機能の理解、進化的関係の確立、タンパク質構造の予測に役立ちます。このような進歩は、特にプロテオミクスとゲノミクスにおけるデータ保存と解析のニーズの高まりに対応することで、市場の成長を促進します。例えば、我々の分析によると、DNA配列決定技術は、ヒトゲノムの配列を約8時間で決定できるようになり、この分野における急速な進歩を示しています。この進歩は、特に老化、がん、遺伝性疾患予防に関連する研究のために、ゲノミクスとバイオインフォマティクス分野の需要を促進しています。これらのバイオインフォマティクスアプリケーションは膨大なデータの管理に役立ち、市場の拡大をさらに後押ししています。しかし、バイオインフォマティクスソフトウェアやサービスの高コスト、熟練した専門家の不足といった課題が、今後の市場成長に制約を与える可能性があります。

市場概要
ナレッジマネジメントツール
- 汎用的な知識管理ツール
- 専門的な知識管理ツール
バイオインフォマティクスプラットフォーム
- データ分析プラットフォーム
- 構造・機能解析プラットフォーム
- その他
バイオインフォマティクスサービス
- シーケンシングサービス
- データ分析サービス
- 創薬サービス
- 遺伝子発現差解析サービス
- データベース・管理サービス
- その他

バイオインフォマティクス市場：用途別

市場概要
ゲノミクス
ケモインフォマティクス・医薬品設計
プロテオミクス
トランスクリプトミクス
メタボロミクス
その他

バイオインフォマティクス市場：セクター別

市場概要
医療バイオテクノロジー
- 創薬・開発
- 臨床診断・個別化医療
- リプロダクティブヘルス
動物バイオテクノロジー
植物バイオテクノロジー
環境バイオテクノロジー
法医学バイオテクノロジー
その他

バイオインフォマティクス市場：ソース別

市場概要
微生物
植物
動物

バイオインフォマティクス市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- イタリア
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Illumina Inc.（US）
Thermo Fisher Scientific Inc.（US）
Qiagen N.V.（Netherlands）
Agilent Technologies Inc.（US）
BGI Group（China）
PerkinElmer Inc.（US）
Eurofins Scientific SE（Europe）
Waters Corporation（US）
DNAnexus Inc.（US）
Sophia Genetics SA（Switzerland）
Partek Incorporated（US）
Gene Codes Corporation（US）
Dassault Systemes SE（France）
Biomax Informatics AG（Germany）
Bruker Corporation（US）
GenoLogics Life Sciences Software Inc.（US）
Nonlinear Dynamics Ltd.（Waters Corporation）（UK）
Genedata AG（Switzerland）
Knome Inc.（US）
Macrogen Inc.（South Korea）

Product Code: SQMIG35H2059

Bioinformatics Market size was valued at USD 13.2 billion in 2022 and is poised to grow from USD 15.35 billion in 2023 to USD 45.6 billion by 2031, growing at a CAGR of 16.3% in the forecast period (2024-2031).

The growth of the market is being significantly driven by increased demand for research and development, coupled with supportive government initiatives. Advances in bioinformatics software, including tools like RasMol, AUTODOCK, and BALL, are also contributing to this expansion. These sophisticated tools enable precise and effective analysis in biomarker discovery programs, which are crucial for detecting toxicity early in drug development processes. Bioinformatics, which involves the use of computer technology to manage and analyze biological data, plays a key role in this sector. It encompasses the storage, evaluation, and dissemination of biological data, aiding in understanding gene and protein functions, establishing evolutionary relationships, and predicting protein structures. Such advancements fuel market growth by addressing the rising need for data storage and analysis, particularly in proteomics and genomics. For instance, based on our analysis, DNA sequencing technology could now sequence a human genome in approximately eight hours, showcasing rapid advancements in the field. This progress is driving demand in the genomics and bioinformatics sectors, especially for research related to aging, cancer, and genetic disease prevention. These bioinformatics applications help manage vast amounts of data, further supporting market expansion. However, challenges such as the high cost of bioinformatics software and services, along with a limited pool of skilled professionals, may pose constraints on market growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioinformatics Market Segmental Analysis

The global bioinformatics market is segmented based on products and services, application, sector, and region. Based on products and services, the market is segmented into knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), bioinformatics platforms (data analysis platforms, structural & functional analysis platforms, other), and bioinformatics services (sequencing services, data analysis services, drug discovery services, differential gene expression analysis services, database and management services, other). Based on application, the market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, and others. Based on sector, the market is segmented into medical biotechnology (drug discovery & development, clinical diagnostics & personalized medicine, reproductive health), animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Bioinformatics Market

The bioinformatics market has experienced significant growth driven by the increasing demand for computational epigenetics, meta-analysis of microarray data, differentially expressed genes, gene networks, and gene-associating studies, among other factors. These advancements highlight the need for sophisticated analysis tools and systems biology requirements, further propelling the market forward.However, challenges such as the absence of standardized protocols and common data formats for integration, coupled with the complexity of data and the shortage of user-friendly tools, are expected to hinder market expansion during the forecast period. These issues may slow progress by complicating data management and analysis processes.

Restraints in the Global Bioinformatics Market

The advent of advanced NGS technologies has heightened the need for fast, precise, and easy-to-use bioinformatics tools. Most experimental researchers lack specialized bioinformatics training, making user-friendly tools essential for effective use of bioinformatics platforms. Many current bioinformatics tools require advanced computing skills and suffer from inadequate user interfaces, which complicates their use for researchers without technical expertise. As a result, the development of more accessible and intuitive bioinformatics solutions is crucial to meet the growing demand for straightforward data analysis in the research community.

Market Trends of the Global Bioinformatics Market

Advancements in systems biology and pharmacogenomics have significantly propelled the shift from traditional, disease-focused medicine to a more integrative, system-based approach centered around individual patient needs. For instance, the launch of the Atlantic Cancer Consortium (ACC) in Canada, backed by over USD 3.6 million in provincial and national funding, underscores this transition. The ACC, composed of Canadian researchers, aims to develop precision medicine for cancer, highlighting the increased collaboration among medical institutions, governments, and researchers to expedite the creation of effective treatments. In addition, partnerships such as that between Summit Biolabs Inc. and the Colorado Center for Personalized Medicine (CCPM) demonstrate the growing emphasis on personalized medicine. This collaboration focuses on research and commercialization of saliva-based liquid-biopsy tests for early cancer detection and diagnosing viral infections like COVID-19. The expansion of companion diagnostics to support personalized medicine in non-oncological cases is also driving market growth. The rising incidence of cancer, in particular, fuels demand for tailored cancer therapeutics and diagnostics, further advancing the field of personalized medicine.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Case Study Analysis
Ecosystem of the Market
Customer & Buying Criteria Analysis
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Bioinformatics Market by Product & Service

Market Overview
Knowledge Management Tools
- Generalized Knowledge Management Tools
- Specialized Knowledge Management Tools
Bioinformatics Platforms
- Data Analysis Platforms
- Structural & Functional Analysis Platforms
- Other
Bioinformatics Services
- Sequencing Services
- Data Analysis Services
- Drug Discovery Services
- Differential Gene Expression Analysis Services
- Database and Management Services
- Other

Bioinformatics Market by Application

Market Overview
Genomics
Chemoinformatics & Drug Design
Proteomics
Transcriptomics
Metabolomics
Other

Bioinformatics Market by Sector

Market Overview
Medical Biotechnology
- Drug Discovery & Development
- Clinical Diagnostics & Personalized Medicine
- Reproductive Health
Animal Biotechnology
Plant Biotechnology
Environmental Biotechnology
Forensic Biotechnology
Other

Bioinformatics Market by Source

Market Overview
Microorganisms
Plants
Animals

Bioinformatics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Europe)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNAnexus Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sophia Genetics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Partek Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gene Codes Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dassault Systemes SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomax Informatics AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenoLogics Life Sciences Software Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nonlinear Dynamics Ltd. (Waters Corporation) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genedata AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Knome Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macrogen Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments